Name : Ahmed Abd El-Bary Abd El-Rahman
Born : August 15, 1938, Sohag, Egypt
Address : Home:
17, Ghazza Street, El-Mohandesseen, Guiza, Egypt
Tel. No. 346 23 39
Office:
Faculty of Pharmacy,
Kasr El-Aini Street
Cairo, Egypt
Tel. No.3628426
Fax: + 202 362 5865
Marital Status: Married, Have 3 Children
Qualifications: - B. Pharm., Faculty of Pharmacy, Cairo University, 1962.
- M. Pharm., Faculty of Pharmacy, Cairo University, 1967.
- Ph. D. Pharmaceutics, Faculty of Pharmacy, Cairo University, 1970.
- Post Doctoral Associate in School of Pharmacy, University of Georgia, USA, 1979 - 1981.
- Present Occupation: Professor of Pharmaceutics, and Direction of Center of Applied Research and Advanced Studies, Faculty of Pharmacy, Cairo University.
- Post Graduate Activities: Dean, Faculty of Pharmacy, Cairo University 1993 - 1998
- Vice Dean for Education and Students Affairs, Faculty of Pharmacy, Cairo University, 1987 - 1993.
- Department of Pharmaceutics, Faculty of Pharmacy, Cairo University:
- Professor since 1980
- Associate Professor 1975 - 1980.
- Assistant Professor 1970 - 1975.
- Instructor 1964 - 1970.
Current University Affiliations With Titles:
Teaching and supervising a course in pharmaceutics to both undergraduate and postgraduate students at the Faculty of Pharmacy:
- Cairo University.
- Mansourah University.
- Assiut University.
- Zagazig University.
* Supervisor on Ph. D. and M. Pharm. Thesis.
* Research consultant, C.I.D. Pharmaceutical Company and El- Nasr Pharmaceutical Company and others.
* Consultant for NODCAR (National Organization for Drug Research and Control).
* Leading a training program for continuous education for pharmacists.
* Leading a training program for hospital pharmacists in Egypt.
* Leader for more than 60 bioequivalence studies.
Honours and Professional Societies/Associations/Affiliations:
* Egyptian Pharmaceutical Syndicate.
* Head of the Egyptian Pharmaceutical Society since 1992.
* Head of the Egyptian Society of Hospital Pharmacy.
* Head of the Committee of the Egyptian Pharmacopoeia since 1997.
* Head of the Committee of the Arab Pharmacopoeia.
* Member the Arabian Union of Pharmacists.
* Staff Members Club of Cairo University.
* Cairo Egyptian Pharmaceutical Syndicate.
* Member of Board of Club of Pharmacists.
* Granted National Prize on Medical Science in 1984.
* Granted the Egyptian Republic Order of Sciences and Art First Level in 1985.
* Head of the Arab Academy of Science since 1992.
* Editor, Egyptian Journal of Pharmaceutical Science.
* Member of the Board of NODCAR.
* Member of New York, Academy of Science USA.
* Member of the Committee of drug registration, Ministry of health and population.
Scientific Books:
Biopharmaceutics and Pharmacokinetic.
Guidelines for Good Hospital Practics.
Guielines for Good Storage Practice.
Egyptian Hospital Formulary.
Guidelines for Good Pharmacy Practice of Pharmaceuticals In Egypt.
Guidelines for Handling of Cytotoxic Drugs.
Guidelines for Quality Control of Cosmetics.
Publications:
1.Technological Formulation of a Stable Paracetamol Phenobarbital Suppository; Bull. Fac. Pharm., Cairo University, Vol. X No. 1, 131 (1971).
2. Stability of Fluid Extract of Liquorice; Bull. Fac. Pharm., Cairo University, Vol. XI, No. 1, 219 (1972).
3. Formulation and Stabilization of Phenylbutazone Sodium Injectable Solution; Bull. Fac. Cairo University, Vol. XI No. 1, 161 (1972).
4. Stability of Phenylbutazone in Ointments; Bull. Fac. Pharm., Cairo University, Vol. XI, No. 1, 189 (1972).
5. Technological Formulation of Triacetyloleandomycin Hard Gelatin Capsules; Bull. Fac. Pharm., Cairo University, Vol. XI, No. 1, 233 (1972).
6. Technological Formulation of Triacetyloleandomycin Oral Suspension; Bull Fac. Pharm., Cairo University, Vol. XI, No. 1, 303 (1972).
7. Formulation of L-Chloramphenicol Hard Gelatin Capsules; Bull. Fac. Pharm., Cairo University, Vol. XI, No. 2, 221 (1972).
8. Formulation of Chewable L-Ascorbic Acid Tablets; Bull. Fac. Pharm., Cairo University, Vol. XII, No. 1, 1 (1973).
9. Spermicidal Activity of Phenylmercuric Nitrate With and Without Other Spermicides in Ointments Using Human Sperms; Bull. Fac. Pharm., Cairo University, Vol. XII, No. 2, 25 (1973).
10.Physical Parameters and Release of Antazoline Hydrochloride Suppositories as a Function of Particle Size, Concentration and Nature of the Base; Proc. XII Conf. Pharm. Sci., Cairo, Egypt, 187 (Feb. 1974).
11.Formulation of Some Contraceptive Pessaries; Bull. Fac. Pharm., Cairo University, Vol. XII, No. 1, 67 (1974).
12.Release and Antimicrobial Properties of Iodine in Certain Pharmaceutical Gels; Bull. Fac. Pharm., Cairo University, Vol. XIII, No. 1, 77 (1974).
13.Effect of Certain Hydrocolloids on the Stability of Liquid Paraffin Emulsion; Bull. Fac. Pharm., Cairo University, Vol. XIII, No. 1, 23 (1974).
14.In-Vitro Release of Noramidopyrine Methansulfonate as a Function of Partiele Size and Concentration; Die Pharmazie, 30, H, 7, 475 (1975).
15.In-Vitro Release of Chloramphenicol from Different Suppository Bases; Die Pharmazie, 30, H. 7, 472 (1975).
16.Evalution of Certain Spermicidal Formulations; Bull. Fac. Pharm., Cairo University, Vol. XIV, No. 1, 155 (1975).
17.Spermicidal Activity of Quinine Bisulphate With and Without Other Spermicides in Ointments Using Human Sperms; Bull. Fac. Pharm., Cairo University, Vol. XIV, No. 2, 199 (1975).
18.Formulaion and Bioavailability of Trisulphonamide Suspension; Bull. Fac. Pharm., Cairo University, Vol. XIV, No. 1,55 (1975).
19.Physicochemical Stability and Bioavailability of Antazoline Hydrochloride Suppositories; Bull. Fac. Pharm., Cairo University, Vol. XIV, No. 2, 239 (1975).
20.Stability of Hydrogen Peroxide in Certain Pharmaceutical Gels; J. Cosmetics and Toiletries,91, 54 (1976).
21.Formulation and Stabilization of Antazoline Hydrochloride Nasal Drops; Bull. Fac. Pharm., Cairo University, Vol. XV, No. 1, 161 (1976).
22.Formulation of Vaginal Contraceptive Foaming Tablets; Bull. Fac. Pharm., Cairo University, Vol. XV, No. 1, 81 (1976).
23.Reliability, Safety and Stability of Vaginal Contraceptive Foaming Tablets Containing Parabens Mixture; Bull. Fac. Pharm., Cairo University, Vol. XV, No. 1, 107 (1976).
24.Formulation of Phenylbutazone Tablets; Bull Fac. Pharm., Cairo University, Vol. XV, No. 1, 193 (1976).
25.Formulation of Phenylbutazone Suspension; Bull. Fac. Pharm., Cairo University, Vol. XV, No. 1, 177 (1976).
26.Effect of Vehicles on the Spermicidal Potency of Certain Drugs; Die Pharmazie, 32, H. 7, 403 (1977).
27.Physical Parameters of Chlorpheniramine Maleate Suppositories and its Release as a Function of Particle Size, Concentration, and Nature of the Base; Die Pharmazie, 32, H. 8/9, 515 (1977).
28.Formulation and Stabilization of Nystatin Pessaries; Bull. Fac. Pharm., Cairo University, Vol. XVI, No. 1, 1 (1977).
29.Formulation and Stabilization of Furazolidone Pessaries; Bull. Fac. Pharm., Cairo University, Vol. XVI, No. 1, 37 (1977).
30.In-Vitro and In-Vivo Evaluation of Chloramphenicol from Acrylic Resin Coprecipitates; Bull. Fac. Pharm., Cairo University, Vol. XVII, No. 1, 17 (1978).
31.Effect of Certain Additives on the Rheological Characteristics of Auby Gum X Mucilage; Bull. Fac. Pharm., Cairo University, Vol. XVII, No. 1, 29 (1978).
32.Kinetics of Paracetamol Release from Suppositories; Bull. Fac. Pharm., Cairo University, Vol. XVII, No. 1, 1 (1978).
33.Availability of Norethisterone from Combined Oral Contraceptive Tablets; Die Pharmazie, H. 1, 49 (1979).
34.Rectal Absorption Profile of Chloramphenicol in Dogs; Pharm. Ind., 41, 1, 91 (1979).
35.Correlation Between the Spermicidal Activity and the Haemolytic Index of Certain Plant Saponins; Die Pharmazie, 34, H. 9, 560 (1979).
36.Release Characteristics of Phenylbutazone From Different Suppository Bases; Bull. Fac. Pharm., Cairo University, Vol. XVIII, No. 2, 155 (1979).
37.Characteristics of Oxyphenbutazone Release From Suppositories; Die Pharmazie, 35, H. 3, 171 (1980).
38.Availability of Oxyphenbutazone From Different Suppository Bases; Die Pharmazie, 35, H. 4, 213 (1980).
39.Formulation of Rapidly Disintegrable Vaginal tablets; Bull. Fac. Pharm., Cairo University, Vol. XIX, No. 1, 243 (1980).
40.Effect of Different Plasticizers on the Release of Chloramphenicol From its Microcapsules; Bull. Fac. Pharm., Cairo University, Vol. XX, No. 1, 107 (1981).
41.Investigation of the Discoloration Developed in Aged Chloramphenicol Suppositories; Die Pharmazie, 36, H. 6, 362 (1981).
42.Pharmacokinetics of Serum Albumin Binding and Release of Certain sulfonylureas; Pharm. Ind., 7, 681 (1981).
43.Interaction of Carbopol 934 with Certain Antihistaminic Drugs; Die Pharmazie, 36, H. 5, 356 (1981).
44.Binding of Xanthine Derivative to Human Serum Albumin as a Function of pH; Acta Pharm. Suec., 18, 379 (1981).
45.Effect of HLB, Concentration and Nature of Surfactant on the Release of Salicylates From Oleagenous Suppository Base; Canad. J. Pharm. Sci., 16, 49 (1981).
46.Reactivity of Various Antacids as a Function of Adsorption of Certain Antihistaminic Drugs; Bull. Fac. Pharm., Cairo University, Vol. XX, No. 1, 185 (1981).
47.A new Concept for Oxyphenbutazone Gel Formulation Using Methacrylate and Carboxy Vinyl Polymers; Pharm. Ind., 44, 12, 1284 (1982).
48.Effect of Albumin Conformation on the Binding of Phenylbutazone and Oxyphenbutazone to Human Serum; J. Pharm. Sci., 71, 2, 241 (1982).
49.Standards For a Good Toothpaste; Bull. Fac. Pharm., Cairo University, Vol. XXI, No. 1, 217 (1982).
50.In-Vitro Release of Paracetamol From Different Suppository Bases; Pharm. Ind., 45, 1, 87 (1983).
51.Rectal Absorption Profile of Paracetamol From Different Suppository Bases; Pharm. Ind., 45, 3, 307 (1983).
52.Interaction of Mefenamic Acid With Certain Human Plasma Proteins and Their Substitutes; 43 rd International Congress of Pharmaceutical Science, Montreux 5-9 Sep. (1983).
53.Dissolution Rate of Chloramphenicol From Hard Gelatin Capsules as a Function of Type of Adjuvants and Method of Granulation; Die Pharmazie, 39, H. 2, 110 (1984).
54.Efficacy of Different Emulsifying Agents in Preparing O/W/O or W/O/W Multiple Emulsions; Pharm. Ind., 46, 964 (1984).
55.Effect of Certain Binders on the Physical and Rheologicl Characteristics of Calcium Carbonate Toothpastes; XVII Conf. of Pharm. Sci. Held In Cairo in 23-26 Feb. (1982).
56.Rheological Properties of Certain Binder Solutions as a Function of Other Toothpaste Ingredients; Egypt, J. Pharm. Sci., 26, No. 1-4, 225 (1985).
57.Factors Affecting Drug Release From Different Polymeric Films; Bull. Fac. Pharm., Ciro University, Vol. XXIV, No. 1, 157 (1985).
58.Interaction of Trimethoprim With Human Serum Albumin; Egypt. J. Pharm. Sci., 27, No. 1-4, 113 (1986).
59.Interaction of Chlorpheniramine Maleate With Carrageenan; Egypt. J. Pharm. Sci., 27, No. 1-4, 103 (1986).
60.Binding of Ibuprofen to Human Serum Albumin as a Function of pH, Serum Albumin and Heavy Metal Ions; First Int. Conf. App. Sci., Vol. 1, (1986).
61.Formulation of Liquid Controlled - Release Dosage Forms of Chlorpheniramine Maleate, I ; Ion Exchange Resin System. Proceedings of 4 th International Conference on Pharmaceutical Technology, 79 June 1986.
62.Formulation of Liquid Controlled - Release Dosage Forms of Chlorpheniramine Maleate, II ; Multiple Emulsions. Proceedings of 4th Interational Conference on Pharmaceutical Technology. 299 June 1986.
63.A pharmaceutical Study on the Micro-Encapsulation of Chlorpheniramine Maleate; Proceedings of 4th International Conference on Pharmaceutical Technology, 245 June 1986.
64.Kinetics of Glucose and Yield of Multiple Emulsions as a Function of Different Formulation Factors; Egypt. J. Pharm. Sci. 28, No. 1-4, 327 (1987).
65.Binding of Certain Anti-Inflammatory Drugs to Plasma Protein of Diabetic Patients; Bull. Fac. Pharm. Cairo University, Vol. XXVI, No. 1, (1987).
66.Certain Binding Characteristics of Azapropazone to Human Serum Albumin; Bull. Fac. Pharm., Cairo University, Vol. XXVI, No. 1, (1987).
67.Development and Application of a Spectrophotometric Method for the Quantitation of Metoclopropamide in Urine; Egypt. J. Pharm. Sci., 29, No. 1-4, 493 (1988).
68.Pharmacokintics of Salicylate in Bilharzial Patients; Egypt. J. Bilh., 10, No. 1, 61 (1988).
69.Microencapsulation of Mebeverine Hydrochloride Resinates; Proceeding of XXI Conf. of Pharm. Sci., 20 Feb. (1989).
70.Physical Stability and Rheological Properties of W/O/W Emulsions as a Function of Electrolytes; Pharm. Ind., 52, 3, 357 (1990).
71.Controlled Crystallization of Chloropropamide From Surfactant and Polymer Solution; Drug Develop. Ind. Pharm. (1990).
72.In-Vitro and In-Vivo Release of Meclazine Hydrochloride From its Suppositories; Bull. Fac. Pharm., Cairo University, Vol. 29, No. 1, (1991).
73.A Bioequivalence Studdy on Piroxicam from Different Capsule Brands; Proceedings of XXII Conference of Pharmaceutical Sciences, Egypt, 1, 1991.
74.Interaction of Sulfamethoxazole With Human Serum Albumin as a Function of pH and Buffer Ion Composition; Egypt. J. Med. Sci. (In Press).
75.Interaction of Indomethacin With Certain Human Plasma Proteins and Their Substitutes; Egypt. J. Pharm. Sci. (In Press).
76.Bioavailability of Glibenclamide; Bull. Fac. Pharm. Cairo University. (In Press).
77.Correlation of In-Vitro and In-Vivo Availability of Indomethacin From Different Dosage Forms; Proceedings of 22 nd Conference of Pharmaceutical Sciences, Egypt, 30, 1991.
78.In-Vitro In-Vivo Correlation of Paracetamol Availability From Suppositories as a Function of the Technique used; Proceedings of 22 nd Conference of Pharmaceutical Sciences, Cairo, Egypt, 55, 1991.
79.In-Vitro and In-Vivo Availability of Paracetamol From Different Commercial Tablets in Egypt; Bull. Fac. Pharm. Cairo University, 29, 3, 27, 1991.
80.Formulation and Bioavailability of Rifampicin Suspension; Egypt. J. Pharm. Sci., 33, 997, 1992.
81.Formulation and Bioavailability of Rifampicin Capsule; Egypt. J. Pharm. Sci., 33, 1013, 1992.
82.Temperature Cycling for Prediction of Aging of Toothpastes; Bull. Fac. Pharm. Cairo University, 31, 2, 255, 1993.
83.Biopharmaceutical Evaluation of Tenoxicam Suppositiories; Bull. Fac. Pharm. Cairo Univ., Vol. 33 No. 1, 51, 1995.
84.Formulation and Evaluation of Tenoxicam Capsules; Bull. Fac. Pharm. Cairo Univ., Vol. 33 No. 1, 59, 1995.
85.Dissolution Performance and Relevant In-Vivo Studies of Piroxicam Capsules; Bull. Fac. Pharm. Cairo Univ., Vol. 33 Special Issue, 75, 1995.
86.Effect of Gamma-Radiation on the Sn (II) Content Radiochemical Purity, In-Vitro Stability and Biological Distribution of Some 99m Tc-Labelled Freeze Dried Kits: Journal of Radioanalytical and Nuclear Chemistry, Articles, Vol. 196, No.1 45-55 (1995).
87.The Application of Experimental Designs in Studying The Availability of Griseofulvin From Tablet Dosage Forms.
Bull. Fac. Pharm. Cairo Univ., Vol 34.No.2. 161, (1996)
88.Agreement Between Pooled Sample Technique and Trapezoidal Rule in Determining the Bioequivalence of Certain Metronidazole Tablets:
Bull. Fac. pharm. Cairo Univ., 34 (3) 203, 1996.
89.Effect of Chemical Structure on the Release of Certain Propionic Acid Derivatives from Their Dosage Forms.
Bull. Drug Development and Industrial Pharmacy, 24 (5), 1-7 (1998).
90.Preparation and Evaluation of Freeze-Dried MAG3 Kits for 99mTc-Labelling.
91.Organic Synthesis and Direct Labelling of Benzoyl Protected Mercaptoacetyltriglycine (S-BZ-MAG3) with Technetium - 99m as Tubular Function Agent.
92. In Vitro and In Vivo Evaluation of Formulated Lidocaine Dental Gels and Ointments.
Egypt. J. Pharm. Sci 38, No 4-6, 471-486 (1997).
93. Formulation of Meloxicam Suppositories.
AZ. J. Pharm. Sci, Vol. 23, (1999).
94. Polymorphic Transformation of Losartan.
Egypt J. Pharm. Sci., 40, (1), 49-59 (1999).
95. Formulation and Evaluation of Controlled Release Ketoprofen Granules Prepared by Pan Coating Method.